Dr. Izidor Mlakar won in September 2022 the BosomShield project in the tender Horizon Europe HORIZON-MSCA-2021-DN-01-01. BosomShield proposes to join the two disciplines (pathological and radiological imaging) in a software that will analyse these images to classify the breast cancer subtypes and predict (together with the complete clinical history of the patient) the probability of relapse for distant metastasis. In addition, BosomShield will provide high-level training in breast cancer research to young researchers by offering the necessary transferable skills for thriving careers underpinned using diverse disciplines, digital radiology and pathology, biomedical, AI, privacy and software development. The consortium of BosomShield has ten beneficiaries and twelve associated partners. (Marie Skłodowska-Curie Actions (MSCA))